References of "Dramaix, M"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailThe impact of concomitant rhinitis on asthma-related quality of life and asthma control.
Vandenplas, O.; Dramaix, M.; Joos, G. et al

in Allergy (2010)

To cite this article: Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G, Vincken W, Vints A-M, Herbots E, Bachert C. The impact of concomitant rhinitis on asthma-related quality of life and ... [more ▼]

To cite this article: Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G, Vincken W, Vints A-M, Herbots E, Bachert C. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy 2010; DOI: 10.1111/j.1398-9995.2010.02365.x. Abstract Background: Characterizing the interactions between the upper and lower airways is important for the management of asthma. This study aimed at assessing the specific impact of concomitant rhinitis on asthma-related quality of life (QOL) and asthma control. Methods: A cross-sectional, observational survey was conducted among 1173 patients with asthma (aged 12-45) recruited by general practitioners and chest physicians. AR was defined by self-reported rhinitis symptoms and previously documented sensitization to inhalant allergens. The primary outcomes were (1) asthma control assessed by the Asthma Control Questionnaire (ACQ) and (2) asthma-specific QOL evaluated through the Mini Asthma Quality of Life Questionnaire (mAQLQ). Results: AR was present in 73.9% of the population with asthma and nonallergic rhinitis (NAR) in 13.6%. AR and NAR were associated with an increased risk of uncontrolled asthma (i.e. ACQ score > 1.5) with adjusted odds ratios (OR) of 2.00 (95% confidence interval [CI]: 1.35-2.97) and 1.77 (95%CI: 1.09-2.89), respectively. Multivariate linear regression analysis showed that AR and NAR had a modest, although significant, negative impact on the global mAQLQ score (beta coefficient: -0.293, standard error [SE]: 0.063 and beta coefficient: -0.221, SE: 0.080, P < 0.001, respectively), even after adjustment for the level of asthma control and demographic characteristics. Conclusion: This survey provides direct evidence that AR and NAR are associated with an incremental adverse impact on the disease-specific QOL of patients with asthma and the level of asthma control. Further investigations are required to determine whether appropriate treatment of rhinitis would efficiently reduce asthma morbidity. [less ▲]

Detailed reference viewed: 28 (3 ULg)
Full Text
Peer Reviewed
See detailAlcohol consumption and the prevalence of metabolic syndrome : a meta-analysis of observational studies
Alkerwi, A; Boutsen, M; Vaillant, M et al

Poster (2009)

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailDeux protocoles d’hyperimmunisation au moyen de vaccins marqués réduisent l’incidence de séroconversion envers l’herpèsvirus bovin 1 en cheptels laitiers : résultats d’une étude sur le terrain
Dispas, M.; Lemaire, Mylène; Speybroeck, N. et al

in Annales de Médecine Vétérinaire (2004), 148(1), 47-61

A 28 months long cohort study was organized in dairy herds in Belgium, to assess the efficacy of hyperimmunisation as a tool for the control of infectious bovine rhinotracheitis. Two protocols of ... [more ▼]

A 28 months long cohort study was organized in dairy herds in Belgium, to assess the efficacy of hyperimmunisation as a tool for the control of infectious bovine rhinotracheitis. Two protocols of hyperimmunisation in which glycoprotein-E deleted marker vaccines were repeatedly administered were compared to a positive control group in which the usual vaccination protocols were authorised. The two hyperimmunisation protocols differed in the primovaccination : the first group was treated with an attenuated vaccine firstly given intra-nasally then by intramuscular route whereas the second group was given an inactivated vaccine by subcutaneous injection. Afterwards, booster vaccinations were the same in both groups : an inactivated vaccine was administered by subcutaneous route every 6 months. In the control group, as a rule, part of the herd was vaccinated annually. For each group, 6 half-yearly reports specify : 1. the evolution of the population, categorized by birth half-year, 2. the incidence of seroconversion against gE in the cohorts and 3. the evolution of the gE seroprevalence. The survival curves of the hyperimmunised groups show a significantly higher proportion (P < 0,001) of animals remaining seronegative against glycoprotein- E compared to the positive control group. No significant difference was shown between the two protocols of hyperimmunisation. Both of them could then be used as tools for the control of infectious bovine rhinotracheitis. [less ▲]

Detailed reference viewed: 49 (0 ULg)